Peter D Haytaian has sold stock and made no open-market buys since Aug 2018

Peter D. Haytaian is an individual corporate executive who most recently served as Executive Vice President of Elevance Health and President of Carelon and CarelonRx, where he oversaw the strategic direction, performance, and growth of Carelon’s businesses in pharmacy, behavioral health, complex and chronic care, and advanced analytics.( Elevance Health announced in February 2026 that he would transition out of his EVP and Carelon president roles effective May 4, 2026, and continue as a special advisor through December 31, 2026 to support leadership continuity.(

Haytaian joined the company in 2012 and served as one of its most senior executives, previously leading the Commercial and Specialty Business Division, the Government Business Division, Diversified Businesses, and IngenioRx.( Publicly available sources here confirm his long tenure and leadership scope, but do not provide verified education details in the supplied results.(

Written by Perplexity from public sources.